BioArctic AB (BIOA B) NPV

Sell:203.00 SEKBuy:203.20 SEK2.20 SEK (1.10%)

Prices delayed by at least 15 minutes
Sell:203.00 SEK
Buy:203.20 SEK
Change:2.20 SEK (1.10%)
Deal now
Prices delayed by at least 15 minutes
Sell:203.00 SEK
Buy:203.20 SEK
Change:2.20 SEK (1.10%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

BioArctic AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of treatments, which aim at diseases that affect the central nervous system (CNS). Its therapeutic areas encompass neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, complete spinal cord injury, as well as other CNS disorders. The Company owns a technology platform, which develops a range of therapeutic monoclonal antibodies. The Company's pipeline includes product candidates in various clinical phases, such as BAN2401, AE1501, BAN0805, imaging and biochemical biomarkers, BBB-technology and SC0806. The Company also operates through SpineMedical AB.

Key people

Gunilla Osswald
President, Chief Executive Officer
Anders Martin-Loef
Chief Financial Officer, Company Secretary
Rebecca Kastell
Vice President, Head of Human Resource
Mikael Moge
Vice President - Chemistry, Manufacturing and Control
Biljana Rizoska
Vice President - Research, Head of Research
Emilie Ankarcrona Smith
General Counsel, Head of Legal & IP
Oskar Bosson
Head of Investor Relations and Communications
Johanna Falting
Chief R&D Officer, Head of Research & Development
Anna-kaija Groenblad
Chief Commercial Officer
Gabrielle Ahlberg Hillert Hillert
Chief Medical Officer, Head of Clinical & Regulatory Affairs
Eugen Steiner
Independent Chairman of the Board
Par Gellerfors
Director
Lars Lannfelt
Director
Cecilia Edstroem
Independent Director
Anna-lena Engwall
Independent Director
Click to see more

Key facts

  • EPIC
    BIOA B
  • Location
    Sweden
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    SE0010323311
  • Market cap
    SEK 15.02bn
  • Employees
    116
  • Shares in issue
    74.13m
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.